2. Dunne S, et al. A review of the differences and similarities between generic drugs and their originator counterparts, including economic benefits associated with usage of generic medicines, using Ireland as a case study. BMC Pharmacology and Toxicology.2013;14:1-19.

3. 平其能. 原创新药的价值. 临床药物治疗杂志.2007;5(2):10-13.

4. 李新刚, 赵志刚. 从临床疗效角度谈原研药和仿制药的区别. 药品评价.2013;10(12):8.

5. 了解仿制药与原研发药有何不同吗?From internet:

6. Marshall GD. Internal and external environmental influences in allergic diseases. J Am Osteopath Assoc. 2004;104(5 Suppl 5):S1-6.

7. 遗传系数最高的七大疾病. 医药与保健.2013;4:14.

8. 方凤. 过敏原与过敏性疾病. 人民军医.2004;47(12):730-732.

9. Bachert C. The role of histamine in allergic disease: re-appraisal of its inflammatory potential. Allergy. 2002;57(4):287-96.

10. Simons FE, Simons KJ. Histamine and H1-antihistamines: celebrating a century of progress. J Allergy Clin Immunol. 2011;128(6):1139-1150.

11. Pucci S, Incorvaia C. Allergy as an organ and a systemic disease. Clin Exp Immunol. 2008;153 Suppl 1:1-2.

12. 田勇泉 主编. 耳鼻咽喉头颈外科学第6版. 人民卫生出版社.2004年. P72.

13. Ruby Pawankar, et al. World Allergy Organization (WAO) White Book on Allergy. Printed in the United Kingdom, 2011

14. Bousquet J, et al. Allergic Rhinitis and its Impact on Asthma (ARIA) 2008. Allergy 2008: 63 (Suppl. 86): 8–160.

15. 中华医学会耳鼻咽喉头颈外科学会鼻科学组. 变应性鼻炎诊断和治疗指南(2009武夷山).中华耳鼻咽喉头颈外科杂志. 2009;44(12):977-978.

16. 中华医学会耳鼻咽喉头颈外科学分会鼻科学组、小儿学组. 儿童变应性鼻炎诊断和治疗指南(2010年,重庆). 中华耳鼻咽喉头颈外科杂志. 2011;46(1):7-8.

17. 刘辅仁 主编. 实用皮肤科学.2005.P411.

18. Zuberbier T, et al. EAACI/GA(2)LEN/EDF/WAO guideline: management of urticaria. Allergy. 2009;64(10):1427-43.

19. Powell RJ, et al. BSACI guidelines for the management of chronic urticaria and angio-oedema. Clin Exp Allergy. 2007;37(5):631-50.

20. 中华医学会皮肤性病学分会. 荨麻疹诊疗指南(2007版). 中华皮肤科杂志. 2007; 40(10): 591-593.

21. 中华医学会皮肤性病学分会免疫学组. 中国特应性皮炎诊断和治疗指南. 中华皮肤科杂志. 2008; 41(11): 772-773.

22. 中华医学会皮肤性病学分会免疫学组. 湿疹诊疗指南. 中华皮肤科杂志. 2011; 44(1): 5-6.